41. Future antimicrobial stewardship programmes:
For those participants who answered ‘no’ to question 39 – participants anticipated activities in three years from now, on whether their work will be linked to or associated with, an antimicrobial stewardship programme.
42. Name and location:
For those participants who answered ‘yes’ to question 41 – participants disclosures on the name and geographic location of the antimicrobial stewardship programme.
43. Gram negative bacteria:
Participants’ disclosures on the top three gram negative bacteria (where their identities are known or strongly suspected) that are associated with the infections treated in hospitals or clinics. Options: Acinetobacter species, Actinobacillus species, Bacteroides fragilis, Bacteroides sp., Bordetella pertussis, Borrelia burgdorferi, Brucella abortus, Brucella canis, Brucella melitensis, Brucella suis, Campylobacter jejuni, Chlamydia pneumoniae, Chlamydia trachomatis, Chlamydophila pneumoniae, Chlamydophila psittaci, Chlymidia peumoniae, Cyanobacteria, Enterobacter, Erwinia species, Escherichia coli, Francisella tularensis, Fusobacterium nucleatum, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Legionella pneumophila, Leptospira interrogans, Moraxella catarrhalis, Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus bacilli, Pseudomonas aeruginosa, Rickettsia rickettsii, Salmonella typhimurium, Serratia marcescens, Shigella sonnei, Treponema pallidum, Vibrio cholerae, Yersinia pestis or other.
44. Gram positive bacteria:
Participants’ disclosures on the top three gram positive bacteria (where their identities are known or strongly suspected) that are associated with the infections treated in hospi
Copyright©2012 Vocus, Inc.
All rights reserved